Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Skin Manifestations
Description
Dermatologic disorders attendant upon non-dermatologic disease or injury. MeSH
Hierarchy View
Subtype Terms (12)
Cellulite
11 drugs (5 approved, 6 experimental)
Ecchymosis
8 drugs (6 approved, 2 experimental)
Erythema
37 drugs (25 approved, 12 experimental)
Flushing
22 drugs (12 approved, 10 experimental)
Jaundice
8 drugs (4 approved, 4 experimental)
Necrolytic Migratory Erythema
1 approved drug
Pruritus
139 drugs (83 approved, 56 experimental)
Purpura
55 drugs (36 approved, 19 experimental)
Striae Distensae
3 drugs (1 approved, 2 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (2)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (9)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 2 Indications (1)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
